Penetration of telithromycin into the nasal mucosa and ethmoid bone of patients undergoing rhinosurgery for chronic sinusitis

Kuehnel, TS and Schurr, C and Lotter, K and Kees, F (2005) Penetration of telithromycin into the nasal mucosa and ethmoid bone of patients undergoing rhinosurgery for chronic sinusitis. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 55 (4). pp. 591-594. ISSN 0305-7453,

Full text not available from this repository. (Request a copy)

Abstract

Objectives: Telithromycin has a broad spectrum of activity against respiratory tract pathogens including penicillin- and macrolide-resistant streptococci. The aim of the study was to investigate the penetration of telithromycin into nasal tissue following a single oral dose of 800 mg. Patients and methods: A total of 29 patients undergoing rhinosurgery for chronic sinusitis were evaluated. Samples of blood, nasal mucus, nasal mucosa and ethmoid bone were collected during surgery in groups of 5-6 patients after 3, 6, 9, 15 and 24 h following a single oral dose of 800 mg telithromycin. Drug concentrations were determined by HPLC with fluorimetric detection. Results: The highest telithromycin concentrations were observed after 3 h in plasma as well as in all tissues sampled. The mean plasma concentrations were 0.73 mg/L in the 3 h group and 0.02 mg/L in the 24 h group. The concomitant tissue concentrations were higher. The tissue penetration, expressed by the ratio of the area under the concentration-time curve in tissue versus plasma, was 1.0 for nasal mucus, 5.9 for nasal mucosa and 1.6 for ethmoid bone. Conclusions: Telithromycin achieved tissue concentrations that were generally above the MIC90 for common pathogens in upper respiratory tract infections. These results indicate that telithromycin diffuses rapidly into the nasal tissues and achieves high and prolonged concentrations in nasal mucosa and ethmoid bone.

Item Type: Article
Uncontrolled Keywords: AZITHROMYCIN; HMR-3647; PHARMACOKINETICS; ROXITHROMYCIN; ANTIBIOTICS; DIFFUSION; LUNG; ketolides; pharmacokinetics; nasal tissue
Subjects: 600 Technology > 610 Medical sciences Medicine
600 Technology > 615 Pharmacy
Divisions: Medicine > Lehrstuhl für Hals-Nasen-Ohren-Heilkunde
Chemistry and Pharmacy > Institute of Pharmacy > Pharmacology and Toxicology (Prof. Schlossmann, formerly Prof. Seifert)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 17 May 2021 13:18
Last Modified: 17 May 2021 13:18
URI: https://pred.uni-regensburg.de/id/eprint/36305

Actions (login required)

View Item View Item